本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

200.62
+0.25500.13%
成交量:7.13万
成交额:1,413.98万
市值:40.00亿
市盈率:32.73
高:201.07
开:200.78
低:195.45
收:200.36
52周最高:227.92
52周最低:93.58
股本:1,994.11万
流通股本:1,945.76万
量比:0.72
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):6.13
每股收益(LYR):6.13
净资产收益率:13.47%
总资产收益率:2.36%
市净率:3.93
市盈率(LYR):32.73

数据加载中...

2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities